BVVBY vs. MEDP
BVVBY (Bureau Veritas SA) and MEDP (Medpace Holdings, Inc.) are both stocks. BVVBY operates in Consulting Services (Industrials), while MEDP operates in Diagnostics & Research (Healthcare). Over the past 3 years, BVVBY returned 8.07%/yr vs 32.19%/yr for MEDP. At a 0.30 correlation, their price movements are largely independent.
Performance
BVVBY vs. MEDP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BVVBY achieves a -4.24% return, which is significantly higher than MEDP's -7.42% return.
BVVBY
- 1D
- -0.77%
- 1M
- -2.74%
- YTD
- -4.24%
- 6M
- -4.61%
- 1Y
- -4.75%
- 3Y*
- 8.07%
- 5Y*
- —
- 10Y*
- —
MEDP
- 1D
- 1.40%
- 1M
- 21.17%
- YTD
- -7.42%
- 6M
- -9.08%
- 1Y
- 67.11%
- 3Y*
- 32.19%
- 5Y*
- 23.60%
- 10Y*
- —
BVVBY vs. MEDP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BVVBY Bureau Veritas SA | -4.24% | 9.04% | 22.87% | -0.75% | -19.52% | 6.33% |
MEDP Medpace Holdings, Inc. | -7.42% | 69.05% | 8.38% | 44.31% | -2.40% | 23.39% |
Correlation
The correlation between BVVBY and MEDP is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2021 | 0.30 |
Fundamentals
BVVBY:
$13.13B
MEDP:
$15.06B
BVVBY:
€5.15
MEDP:
$15.63
BVVBY:
10.06
MEDP:
33.26
BVVBY:
1.22
MEDP:
1.00
BVVBY:
0.91
MEDP:
5.72
BVVBY:
6.75
MEDP:
25.17
BVVBY:
€12.78B
MEDP:
$2.68B
BVVBY:
€5.30B
MEDP:
$778.59M
BVVBY:
€2.15B
MEDP:
$572.96M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BVVBY vs. MEDP — Risk / Return Rank
BVVBY
MEDP
BVVBY vs. MEDP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bureau Veritas SA (BVVBY) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BVVBY | MEDP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.18 | ||
| Sortino ratioReturn per unit of downside risk | -2.21 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.36 | -0.38 |
| Calmar ratioReturn relative to maximum drawdown | -0.32 | 1.84 | -2.16 |
| Martin ratioReturn relative to average drawdown | -0.61 | 3.97 | -4.58 |
Loading charts...
Drawdowns
BVVBY vs. MEDP - Drawdown Comparison
The maximum BVVBY drawdown since its inception was -35.90%, smaller than the maximum MEDP drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for BVVBY and MEDP.
Loading charts...
Drawdown Indicators
| BVVBY | MEDP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.90% | -42.87% | +6.97% |
Max Drawdown (1Y)Largest decline over 1 year | -15.06% | -36.61% | +21.55% |
Max Drawdown (3Y)Largest decline over 3 years | -20.12% | -39.38% | +19.26% |
Max Drawdown (5Y)Largest decline over 5 years | — | -42.87% | — |
Current DrawdownCurrent decline from peak | -12.60% | -16.22% | +3.62% |
Average DrawdownAverage peak-to-trough decline | -12.78% | -12.96% | +0.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.76% | 16.97% | -9.21% |
Volatility
BVVBY vs. MEDP - Volatility Comparison
The current volatility for Bureau Veritas SA (BVVBY) is 7.60%, while Medpace Holdings, Inc. (MEDP) has a volatility of 10.60%. This indicates that BVVBY experiences smaller price fluctuations and is considered to be less risky than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BVVBY | MEDP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.60% | 10.60% | -3.00% |
Volatility (6M)Calculated over the trailing 6-month period | 19.88% | 38.83% | -18.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.30% | 69.49% | -46.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.36% | 51.72% | -27.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.36% | 49.77% | -25.41% |
Dividends
BVVBY vs. MEDP - Dividend Comparison
BVVBY's dividend yield for the trailing twelve months is around 7.18%, while MEDP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
BVVBY Bureau Veritas SA | 7.18% | 3.26% | 2.95% | 3.31% | 2.10% |
MEDP Medpace Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BVVBY vs. MEDP - Financials Comparison
This section allows you to compare key financial metrics between Bureau Veritas SA and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BVVBY vs. MEDP - Profitability Comparison
BVVBY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bureau Veritas SA reported a gross profit of 173.01M and revenue of 3.25B. Therefore, the gross margin over that period was 5.3%.
MEDP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.
BVVBY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bureau Veritas SA reported an operating income of 166.16M and revenue of 3.25B, resulting in an operating margin of 5.1%.
MEDP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.
BVVBY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bureau Veritas SA reported a net income of 263.73M and revenue of 3.25B, resulting in a net margin of 8.1%.
MEDP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.
Frequently Asked Questions
BVVBY and MEDP have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MEDP has higher volatility (10.60%) compared to BVVBY (7.60%). In terms of maximum drawdown, BVVBY dropped -35.90% vs MEDP's -42.87%.
MEDP currently has the higher Sharpe Ratio (0.97 vs -0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BVVBY and MEDP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer